Your browser doesn't support javascript.
loading
Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database study.
Toboni, Michael D; Cohen, Alexander; Gentry, Zachary L; Ostby, Stuart A; Wang, Zhixin; Bae, Sejong; Leath, Charles.
Afiliação
  • Toboni MD; Department of Obstetrics and Gynecology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA MDToboni@wustl.edu.
  • Cohen A; Department of Obstetrics and Gynecology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
  • Gentry ZL; Department of Obstetrics and Gynecology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
  • Ostby SA; Department of Obstetrics and Gynecology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
  • Wang Z; Department of Obstetrics and Gynecology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
  • Bae S; Department of Obstetrics and Gynecology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
  • Leath C; Department of Preventive Medicine, The University of Alabama at Birmingham School of Public Health, Birmingham, Alabama, USA.
Int J Gynecol Cancer ; 32(6): 724-731, 2022 06 06.
Article em En | MEDLINE | ID: mdl-35428687
ABSTRACT

OBJECTIVE:

To determine how sociodemographic factors impact cervical cancer survival in different geographic locations in the USA.

METHODS:

A retrospective cohort of patients with cervical cancer from January 1, 2004 to December 31, 2015 in the National Cancer Database (NCDB) was identified. Tumor characteristics as well as race, income, insurance type, and treating facility types were compared among nine geographic regions. χ2 tests and Cox regression were used to compare differences between regions; p values <0.05 were considered significant.

RESULTS:

A total of 48 787 patients were included. Survival was inferior in seven of nine regions for underinsured patients. In six regions survival was inferior for Medicaid and Medicare patients, respectively Middle Atlantic hazard ratio (HR) 1.25 and 1.22; South Atlantic HR 1.41 and HR 1.22; East North Central HR 1.36 and HR 1.25; East South Central HR 1.37 and HR 1.25; West North Central HR 1.67 and HR 1.42; West South Central HR 1.44 and HR 1.46. In the Pacific region survival was inferior for Medicare patients (HR 1.35) but not inferior for Medicaid patients. Being uninsured was associated with worse survival in the South Atlantic (HR 1.23), East North Central (HR 1.23), East South Central (HR 1.56), and West South Central (HR 1.31) regions. Annual income level under $38 000 was associated with worse survival in the Middle Atlantic (HR 1.24), South Atlantic (HR 1.35), and East North Central (HR 1.49) regions. Lastly, when compared with academic research institutions, comprehensive community cancer centers had significantly worse survival in four of the nine regions.

CONCLUSIONS:

Cervical cancer mortality is higher for women with a low income, underinsured (Medicaid or Medicare) or uninsured status, and decreased access to academic institutions in most US regions. An increase in cervical cancer mortality was associated with underinsured or uninsured populations in regions mainly located in the South and Midwest.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Medicare Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans País/Região como assunto: America do norte Idioma: En Revista: Int J Gynecol Cancer Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Medicare Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans País/Região como assunto: America do norte Idioma: En Revista: Int J Gynecol Cancer Ano de publicação: 2022 Tipo de documento: Article